Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Castaman

Showing results (181-190 of 198) with videos related to

Pageof 20
Sort By:
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter studyF Rodeghiero, G Castaman, A Tosetto, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2006
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter studyG Castaman, F Rodeghiero, A Tosetto, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 2011
A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand diseaseA Tosetto, F Rodeghiero, G Castaman, et al.
Circulation|February 19, 2004
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patientsA Srámek, P Bucciarelli, A B Federici, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Cysteine-mutations in von Willebrand factor associated with increased clearanceC J Schooten, P Tjernberg, E Westein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 23, 2017
Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general populationE Marchesini, E Oliovecchio, A Coppola, et al.
Thrombosis Research|July 24, 2010
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWDG Castaman, A Tosetto, A Cappelletti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 27, 2020
Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrateG Castaman, A Borchiellini, E Santagostino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2012
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand diseaseG Castaman, A Coppola, E Zanon, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Pageof 20

Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter studyF Rodeghiero, G Castaman, A Tosetto, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2006
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter studyG Castaman, F Rodeghiero, A Tosetto, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 2011
A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand diseaseA Tosetto, F Rodeghiero, G Castaman, et al.
Circulation|February 19, 2004
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patientsA Srámek, P Bucciarelli, A B Federici, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Cysteine-mutations in von Willebrand factor associated with increased clearanceC J Schooten, P Tjernberg, E Westein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 23, 2017
Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general populationE Marchesini, E Oliovecchio, A Coppola, et al.
Thrombosis Research|July 24, 2010
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWDG Castaman, A Tosetto, A Cappelletti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 27, 2020
Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrateG Castaman, A Borchiellini, E Santagostino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2012
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand diseaseG Castaman, A Coppola, E Zanon, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Pageof 20